InspireMD (NSPR) Net Income towards Common Stockholders (2010 - 2025)

InspireMD's Net Income towards Common Stockholders history runs 16 years deep, the most recent figure standing at -$75.7 million for Q4 2025.

• On a quarterly basis, Net Income towards Common Stockholders fell 30.89% year-over-year to -$75.7 million in Q4 2025; TTM through Dec 2025 was -$113.2 million, a 38.14% decrease from a year earlier, with the FY2025 full-year figure at -$49.9 million, down 97.7% from the prior year.
• Net Income towards Common Stockholders declined to -$75.7 million in Q4 2025 per NSPR's latest filing, from -$13.1 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at -$3.2 million in Q1 2021 and bottomed at -$75.7 million in Q4 2025.
• The 5-year median for Net Income towards Common Stockholders is -$5.5 million (2023), against an average of -$13.0 million.
• Across the five-year window, Net Income towards Common Stockholders jumped 89.57% in 2021 and slumped 251.69% in 2023, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$4.1 million in 2021, then fell by 18.88% to -$4.8 million in 2022, then slumped by 251.69% to -$16.9 million in 2023, then tumbled by 241.17% to -$57.8 million in 2024, then plunged by 30.89% to -$75.7 million in 2025.
• Per Business Quant, the three latest NSPR Net Income towards Common Stockholders figures stand at -$75.7 million (Q4 2025), -$13.1 million (Q3 2025), and -$13.0 million (Q2 2025).